BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

846 related articles for article (PubMed ID: 20864322)

  • 1. [The use of postnatal corticosteroid therapy in premature infants to prevent or treat bronchopulmonary dysplasia: current situation and recommendations].
    Jarreau PH; Fayon M; Baud O; Autret-Leca E; Danan M; de Verdelhan A; Castot A
    Arch Pediatr; 2010 Oct; 17(10):1480-7. PubMed ID: 20864322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Glucocorticoide therapy in premature infants: French practices in 2006].
    Autret-Leca E; Bauer S; Alberti C; Jonville-Béra AP; Aujard Y; Bensouda-Grimaldi L; Baud O
    Arch Pediatr; 2009 Jul; 16(7):999-1004. PubMed ID: 19410441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhalation or instillation of steroids for the prevention of bronchopulmonary dysplasia.
    Bassler D
    Neonatology; 2015; 107(4):358-9. PubMed ID: 26044104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Policy statement--postnatal corticosteroids to prevent or treat bronchopulmonary dysplasia.
    Watterberg KL;
    Pediatrics; 2010 Oct; 126(4):800-8. PubMed ID: 20819899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Late (≥ 7 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants.
    Doyle LW; Cheong JL; Hay S; Manley BJ; Halliday HL
    Cochrane Database Syst Rev; 2021 Nov; 11(11):CD001145. PubMed ID: 34758507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early (< 7 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants.
    Doyle LW; Cheong JL; Hay S; Manley BJ; Halliday HL
    Cochrane Database Syst Rev; 2021 Oct; 10(10):CD001146. PubMed ID: 34674229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current strategies in the management of bronchopulmonary dysplasia: the role of corticosteroids.
    Knoppert DC; Mackanjee HR
    Neonatal Netw; 1994 Apr; 13(3):53-60. PubMed ID: 8152411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence-based neonatal pharmacotherapy: postnatal corticosteroids.
    Watterberg K
    Clin Perinatol; 2012 Mar; 39(1):47-59. PubMed ID: 22341536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comprehensive approach to the prevention of bronchopulmonary dysplasia.
    Kugelman A; Durand M
    Pediatr Pulmonol; 2011 Dec; 46(12):1153-65. PubMed ID: 21815280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of bronchopulmonary dysplasia in infants: guidelines for corticosteroid use.
    Grier DG; Halliday HL
    Drugs; 2005; 65(1):15-29. PubMed ID: 15610049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postnatal betamethasone vs dexamethasone in premature infants with bronchopulmonary dysplasia: a pilot study.
    DeCastro M; El-Khoury N; Parton L; Ballabh P; LaGamma EF
    J Perinatol; 2009 Apr; 29(4):297-304. PubMed ID: 19052552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [New concepts of corticosteroid treatment in pulmonary diseases of the premature infant].
    Krause M
    Klin Padiatr; 1997; 209(5):308-14. PubMed ID: 9411040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-dose dexamethasone facilitates extubation among chronically ventilator-dependent infants: a multicenter, international, randomized, controlled trial.
    Doyle LW; Davis PG; Morley CJ; McPhee A; Carlin JB;
    Pediatrics; 2006 Jan; 117(1):75-83. PubMed ID: 16396863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of a single dose of antenatal corticosteroids on morbidity and mortality of preterm infants.
    Costa S; Zecca E; De Luca D; De Carolis MP; Romagnoli C
    Eur J Obstet Gynecol Reprod Biol; 2007 Apr; 131(2):154-7. PubMed ID: 16797825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhaled drugs for the prevention and treatment of bronchopulmonary dysplasia.
    Pantalitschka T; Poets CF
    Pediatr Pulmonol; 2006 Aug; 41(8):703-8. PubMed ID: 16779858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postnatal Corticosteroids To Prevent Bronchopulmonary Dysplasia.
    Jensen EA; Watterberg KL
    Neoreviews; 2023 Nov; 24(11):e691-e703. PubMed ID: 37907402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postnatal Corticosteroids to Prevent or Treat Bronchopulmonary Dysplasia.
    Doyle LW
    Neonatology; 2021; 118(2):244-251. PubMed ID: 33975319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [From classic to new bronchopulmonary dysplasia].
    Kramer BW; Lievense S; Been JV; Zimmermann LJ
    Ned Tijdschr Geneeskd; 2010; 154():A1024. PubMed ID: 20456770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Inhaled Nitric Oxide on Survival Without Bronchopulmonary Dysplasia in Preterm Infants: A Randomized Clinical Trial.
    Hasan SU; Potenziano J; Konduri GG; Perez JA; Van Meurs KP; Walker MW; Yoder BA;
    JAMA Pediatr; 2017 Nov; 171(11):1081-1089. PubMed ID: 28973344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Perinatal glucocorticosteroid therapy: time for reconsideration].
    Groneck P
    Z Geburtshilfe Neonatol; 2001; 205(6):231-5. PubMed ID: 11745009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.